ARTICLE | Clinical News
Prototek Inc. regulatory update
January 3, 1995 8:00 AM UTC
The Dublin, Calif., company received U.S. Patent No. 5,374,623 covering peptidyl activated ketone inhibitors containing natural and unnatural peptide sequences. Prototek is developing the protease inh...